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Abstract
Leptospirosis is a disease caused by pathogenic species of spirochetes of the genus Leptospira.
The bacteria are widespread globally and can survive in the environment for weeks after being
excreted through the urine of infected animals. Humans get infected through contact with
contaminated water or soil. Leptospirosis is a life-threatening disease with a wide range of
symptoms. It is believed that after infection, individuals acquire natural immunity against the same
infecting serovar. However, there are over 300 serovars of Leptospira that can cause disease in
humans and animals, and reinfections are common. Nevertheless, recent studies have shown that
reinfection caused by the same serovar is frequent in highly endemic areas, indicating that
antibodies in different individuals may be diverse. Our research has been focusing on trying to
better understand the natural immunity against Leptospira. We conducted experiments to verify if
antibodies against specific leptospiral proteins could induce immunity against secondary infection.
Using mutants and recombinant proteins of the identified targets, we evaluated the role of those
protein candidates on the pathogenesis of the bacteria and on the immunity of individuals living in
an endemic area for leptospirosis. We identified proteins that have a role as a virulence factor and
confirmed the overall role of specific targets as an immunogenic marker for protection. Our
preliminary results indicate that those targets can be explored as potential diagnostic and/or
prevention candidates against this important neglected disease.
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Introduction
Leptospirosis is a zoonotic disease caused by pathogenic spirochetes of the genus Leptospira.
Leptospirosis range from asymptomatic disease to severe cases of liver and renal failure, known
as Weil’s disease or leptospirosis pulmonary hemorrhage syndrome (LPHS) [1]. It is considered a
major public health problem worldwide [2]. The Leptospira genus has 68 species with more than
300 serovars and is classified into four phylogenetic subclades: pathogenic P1 and P2 and
saprophytic S1 and S2 [3]. Leptospira has the ability to colonize the kidney tubules of a wide range
of reservoir mammals, with rats being an important one, without causing disease [4]. The bacteria
are eliminated by their urine, contaminating the environment. Spill-over infections can occur on
susceptible animals, including humans, by contact with the urine or contaminated environment.
Antibodies play an important role in combating the disease[5]. Most antibodies aim at
lipopolysaccharides (LPS) of Leptospira, which is diverse among various strains [6]. A host can
produce agglutinating antibodies after the infection, which are limited to the same serovar of
Leptospira because of different LPS. For that reason, immune response to one serovar of
Leptospira could not give individuals cross-protective immunity to other serovars [7].
Nevertheless, recent studies have shown that individuals with mild and severe leptospirosis have
a strong immune response against specific leptospiral proteins [8] and that impairment of antibody
response can lead to death [9].
We recently performed a case-control study with 126 individuals selected from a longitudinal
cohort of >2,000 individuals living in a slum area in Salvador, Brazil, an endemic region for
leptospirosis. We studied the hypothesis that pre-exposure inversely correlates with the risk of
infection, and antibodies anti-proteins recognized in sera are markers for protection. Based on
serology, we selected individuals with one or more reinfection events (cases) and individuals with

only one infection (controls). Individuals were matched by age, gender, time of collection of sera,
same follow-up, and same recruitment time. Using the proteome array approach in collaboration
with UC Irvine [7, 8], we identified 37 unique proteins (IgM and IgG responses) that are related
to potential protection against reinfection. Of those, 18 (48.6%) were also identified in our
attenuated vaccine model[7], indicating the potential role of protection. For this present study, we
characterized the role of some of those protein targets related to the pathogenesis and immunity of
the pathogen. We evaluated the virulence phenotype of mutants lacking the expression of specific
protein targets and characterized the immune response of individuals with and without reinfection
events to those proteins using an ELISA approach. Studies to better characterize these protein
candidates and understand their role in the immunity against leptospirosis or the biology of the
agent will help to close the gap regarding naturally acquired immunity and the development of
improved prevention and diagnostic methods.

Specific Aim & Hypotheses
This project aims to validate protein candidates that correlate with immune protection against
reinfection in humans and have the potential to improve diagnostic and prevention.
1) We hypothesize that the deletion of one of the protein candidates will affect the virulence of the
strain, indicating a role in the pathogenesis of the disease and highlighting the potential of the
specific protein to be used as a surrogate for protection.
2) We hypothesize that using those proteins in an ELISA platform, we can identify individuals that
had only one infection event, indicating the potential of those proteins to be used as surrogates for
immunity and potential diagnostic markers.

Material and Methods
Leptospira spp. strains and culture
Mutant strains were selected from a library of random mutants generated with Himar1 transposon.
Frozen aliquots of mutants of interest have been kept at -80 ℃. The insertion of the transposon
and confirmation of gene disruption was done using a semi-random PCR. Of the 37 genes that
were identified in our case-control study, 11 (30%) had at least one mutant that could be evaluated
(Table 1). All mutants were generated from L. interrogans serovar Manilae parent strain (wildtype).
The frozen aliquots of mutants or wild type of interest were thawed in liquid EllinghausenMcCullough-Johnson-Harris (EMJH) [10] and kept at 29C for 14 days. After checking for growth,
motility, and lack of contamination, the strains were kept in liquid EMJH, culturing every week
for up to 5-6 weeks, until animal studies. For the challenge experiment, the concentration of
leptospires was determined under a dark-field microscope using a Petroff-Hausser counting
chamber (Fisher Scientific).

Table 1. Genes of interest with mutant strains and/or recombinant protein to evaluate pathogenesis
and immunity
Gene ID

Localization

Mutant

Ig

Recombinant protein

LIC10050

Outer membrane

Yes

IgM

Yes

LIC10465

Outer membrane

Yes

IgM

Yes

LIC11845

Cytoplasmic

Yes

IgG

Yes

LIC11941

Outer membrane

Yes

IgG and &IgM

Yes

LIC10010

Unknown

Yes

IgM

No

LIC10080

Cytoplasmic

Yes

IgM

No

LIC10491

Cytoplasmic

Yes

IgM

No

LIC10544

Unknown

Yes

IgG

No

LIC10829

Extracellular

Yes

IgG

No

LIC11510

Cytoplasmic

Yes

IgM

No

LIC20152

Unknown

Yes

IgG

No

LIC11019

Unknown

No

IgG and IgM

Yes

LIC11073

Extracellular

No

IgG

Yes

LIC11186

Outer membrane

No

IgG

Yes

LIC11623

Outer membrane

No

IgG

Yes

LIC11694

Outer membrane

No

IgG

Yes

LIC12544

Unknown

No

IgG

Yes

LIC13084

Outer membrane

No

IgG

Yes

LIC20016

Cytoplasmic

No

IgG and IgM

Yes

Virulence experiments
The identified mutants were characterized in the hamster model for leptospirosis. Golden Syrian
Hamsters are highly susceptible to leptospirosis and are the model of choice for acute leptospirosis,
emulating the natural history and clinical presentation of severe leptospirosis in humans [11-13].
Three-week-old hamsters were infected with high doses of the spirochete (108 leptospires) through
the intraperitoneal (IP) or conjunctival (CJ) route. A group challenged by the same routes with the
wild-type strain was kept as a control. Animals were observed daily for clinical signs up to 21 days
post-challenge. Surviving animals at the end of the experiment or moribund animals presenting
with difficulty moving, breathing, or signs of bleeding or seizure were immediately sacrificed by
inhalation of CO2. All animal protocols were approved by the Institutional Committee for the Use
of Experimental Animals, Yale University (protocol # 2020-11424). All virulence experiments

were conducted twice for reproducibility. Kidneys were obtained during the euthanasia for further
analysis.

DNA extraction and qPCR
To evaluate the ability of the mutants to cause renal colonization, we extracted kidney DNA to
evaluate by qPCR. DNA was extracted from the kidney cortex using Maxwell® 16 tissue DNA
purification kit (Promega Corporation, Madison, WI), following the manufacturer's instructions
and using a 200 μL elution volume. The concentration of leptospires was quantified by a TaqManbased quantitative-PCR assay using an ABI 7500 system (Thermo Fisher Scientific, Inc.) and
Platinum Quantitative PCR SuperMix-UDG (Thermo Fisher Scientific, Inc.). The qPCR reaction
was performed using lipL32 primers and probes as previously described, with the bacterial
quantification being calculated and expressed as the number of leptospires per milliliter based on
a standard curve [14].

ELISA
According to our case-control study, each target identified was related to IgG and/or IgM response
(Table 1). From our 37 protein candidates, we had recombinant protein from 12 (32.5%) of them
(Table 1). To validate the immunogenicity of those protein targets in human sera, we tested
recombinant proteins using an ELISA assay. To determine the best conditions for the assay, we
evaluated the temperature for coating (room temperature and 37C) and different concentrations
of the protein-based on previous experiments: 50 ng, 100 ng, and 200 ng. We also evaluated the
best dilution of the HRP anti-human secondary antibody: 1:10,000 and 1:25,000. The primary
antibody was used at a dilution of 1:50. For the optimization assay, we used one protein for IgM

(LIC10050) and one for IgG (LIC12544). Protein concentration and quality were measured by
Bradford assay and SDS-PAGE, respectively.
We then selected ten random sera samples from each group of our case-control study to create a
sera pool. The negative control (NTC) sera used was a commercial normal human serum. As a
positive control, we used acute and convalescent sera from leptospirosis patients for IgM and IgG,
respectively. We used the sera pool to validated the results of the proteome array using an ELISA
assay. Proteins were individually coated in 96-well plates at pre-determined concentrations and
evaluated. After using the sera pool to test all proteins (Table 1), we evaluated the recombinant
LIC 20016 protein (IgM and IgG) using individual sera samples from our individuals enrolled in
our case-control study.

Results
Virulence evaluation
In all virulence evaluation experiments, hamsters challenged with the wildtype strain, either by IP
or CJ routes, all died as expected. All mutant strains were evaluated twice using the hamster model.
Mutants LIC10465, LIC10491, LIC11941, and LIC10080 were considered virulent since
mortalities were 100% for both IP and CJ challenged experiments. The remaining mutants (63.7%)
were considered attenuated at different levels, specifically when using the CJ route. Only one
mutant, LIC10050, an outer membrane protein (OMP), was attenuated by IP and CJ route.
Nevertheless, all of the attenuated mutants were unable to cause death on all hamsters when
challenged by CJ route (Table 2).

Table 2. Mortality for IP and CJ route with 95% confidence interval
Strains

Localization

IP mortality (95%CI)

CJ mortality (95%CI)

Attenuated

LIC10050

Outer membrane

33.33% (0.10, 0.7)

16.67% (0.03, 0.56)

Yes

LIC10544

Unknown

100% (0.61, 1)

16.67% (0.03, 0.56)

Yes

LIC20152

Unknown

100% (0.61, 1)

16.67% (0.03, 0.56)

Yes

LIC11510

Cytoplasmic

100% (0.61, 1)

16.67% (0.03, 0.56)

Yes

LIC10829

Extracellular

100% (0.61, 1)

33% (0.10,0.7)

Yes

LIC11845

Cytoplasmic

100% (0.71, 1)

66.67% (0.35, 0.88)

Yes

LIC10010

Unknown

100% (0.80, 1)

73% (0.48, 0.89)

Yes

LIC10465*

Outer membrane

100% (0.61, 1)

100% (0.61, 1)

No

LIC10491

Cytoplasmic

100% (0.61, 1)

100% (0.61, 1)

No

LIC11941

Outer membrane

100% (0.61, 1)

100% (0.61, 1)

No

LIC10080

Cytoplasmic

100% (0.61, 1)

100% (0.61, 1)

No

* Mutant LIC10465 was evaluated by a different member of our group.
Kidneys were collected from hamsters after euthanasia. DNA was then extracted from the kidney
and we performed qPCR to determine renal colonization. Results of qPCR showed that despite the
attenuation phenotype, the mutants were still able to cause colonization on hamsters (Figure 1).
However, compared to wildtype, only three mutant strains had no statistically difference in the
renal burden. Despite the lack of attenuation when using the IP route, mutants LIC11510,
LIC10491, and LIC10829 had significant difference among IP route (Appendix S1).
Furthermore, five of the seven mutants with attenuation on the conjunctival route also showed
reduced renal burden. Interestingly, the only mutant that was attenuated on both challenge routes,
LIC10050, had no differences on the renal burden. Nevertheless, these results confirm the role of
some of those targets on the pathogenesis of the leptospiral agent.

Figure 1. qPCR results for IP route and CJ route. Each bar represents the mean result for the bacterial load (logarithmic scale) of two independent
experiments. The error bars represent the standard deviations.

ELISA evaluation
In order to test the optimal condition of ELISA, we performed an optimization assay to determine
the best concentration of the antigen, best temperature for coating, and best dilution for the
secondary antibody. Our results showed that for both IgM and IgG, the optimal condition was
coating with 50 ng of protein and 1:10,000 secondary antibodies at 37 ℃ (Figure 2).

Figure 2. Optimization of ELISA assay. We evaluated the coating using 50ng, 100ng, 200ng protein and the 1:10,000 and 1:25,000 for dilution
of the secondary antibody. BL was the blank control using 3% BSA solution; NTC was negative control using commercial NHS sera; Human
group used sera from acute leptospirosis patients for IgM and sera from leptospirosis patients in convalescence period for IgG. Hamster group
used sera collected from Leptospira infected hamsters. The rLIC10050 was evaluated using anti-IgM secondary antibody with coating at 37 ℃
(a) and Room Temperature (b). The rLIC12544 was evaluated using anti-IgG secondary antibody with coating at 37 ℃ (c) and Room
Temperature (d).

ELISA was conducted with all proteins available (Table 1), testing for IgG and/or IgM using a
pool of cases and a pool of controls, together with positive and negative controls as described.
Results showed that there was a significant difference between the antibodies in the sera pool of
the case group and control group for all proteins using IgM, while the difference between the case
group and control group for all proteins using IgG was not significant (Figure 3).

Figure 3. ELISA test using sera pool for IgM and IgG. BL was the blank control using 3% BSA solution; NTC was negative control using
commercial NHS sera; CASE was the case group in the case-control study; CONTROL was the control group in the case-control study; Positive
used sera from acute leptospirosis patients for IgM and sera from leptospirosis patients in convalescence period for IgG. a) ELISA of LIC10050,
LIC20016, LIC11019, LIC11073, LIC10465, and LIC11941 using IgM under the optimal ELISA condition; b) ELISA of LIC12544, LIC20016,
LIC11019, LIC11073, LIC11186, LIC11845, LIC11694, LIC13084, and LIC11623 using IgG under the optimal ELISA condition

We then evaluated the recombinant LIC20016 protein with all individual samples. In our casecontrol study, we evaluated 57 cases and 57 controls. Individual ELISA showed little difference
between the case group and control group for both IgM and IgG secondary antibodies. The
difference between the means of the case group and the control group was not statistically
significant. The standard deviation of the case group was 0.251 for IgM secondary antibody, and
it was 0.154 for the control group. For IgG, the SD case was 0.196, and SDcontrol was 0.141. For both
IgM and IgG experiments, the standard deviation of the case group was greater than that of the
control group.

Figure 4. Individual ELISA with rLIC20016: a) ELISA using IgM as the secondary antibody; b) ELISA using IgG as the secondary antibody

Discussion

Humans acquire immunity against leptospirosis to a certain degree after the infection, and the
importance of antibodies in the development of this immunity has been demonstrated [15, 16].
There has been an increased effort to develop vaccines that can elicit cross-immunity to prevent
leptospirosis on different epidemiological settings. Here, we designed a series of experiments to
study the potential value of certain leptospiral proteins on the development of vaccines and
diagnostic tools.
The virulence evaluation showed that out of 11 mutants evaluated, seven of them were attenuated
at some level when compared to the wildtype strain. More specifically, the attenuation seemed to
be more evident when using the conjunctival route of infection. This route is important because it
mimics the natural process of infection, where the strain needs to adhere, penetrate and disseminate
before causing infection. Those steps are somehow lost during the IP challenge, which highlights
the importance of this route and the potential role of those targets during the initial steps of

infection. Despite the attenuation phenotype, all mutants were able to cause renal colonization.
However, the burden of leptospires on the kidney cortex was significantly different, confirming
the survival results. In other words, some of these proteins play an important role in the infection
of Leptospira. Leptospira proteins can be unique and the proteome sometimes redundant, with the
function of many of them still unclear. Even though they are not completely attenuated, they still
contribute to the study of pathogenesis and target research. The deletion of the LigA protein
(LIC10465) alone can’t affect the virulence, but when the expression of both LigA and LigB are
disrupted, the strain becomes attenuated[17, 18]. Given our results, these proteins can be used as
potential targets for the design of vaccines and the study of pathogenesis.
It is important to discuss that, in our experiments, we used a high dose of Leptospira to challenge
the hamsters. The hypothesis was that the lack of expression of one of those targets would lead to
a complete attenuation of the bacterium. However, given our results showing different levels of
attenuation, it would be appropriate to perform a LD50 experiment with each mutant strain on both
routes of challenge, to determine if the attenuation could be related to lower doses of infection.
The next stage of experiments should also include the complemented strains of the mutants to
confirm the effect of virulence.
Our ELISA results revealed that the sera pool from individuals who got infected only once had
more reaction with proteins related to IgM immune response than the sera pool from individuals
who got more than once infection. However, there was no significant difference between the sera
pool from the case group and the control group when using proteins related to IgG response. When
thinking about diagnostic, especially early diagnostic, our results are optimistic since IgM is the
first antibody response after infection. Those targets can potentially be used to improve the
diagnostic of leptospirosis specially in endemic regions where reinfections are common. The

results with the IgG targets need to be better explored in the future. We only selected ten sera
samples randomly to make the sera pool. The pool strategy was used given the large number of
protein targets and individuals to be tested. It is possible that by testing a pool with all individuals
the results would be different and more accurate, given that the immune response to those targets
vary among individuals. It is also possible that the IgG response to individual proteins might need
better optimization. We only used one specific protein as representative of each Ig and potentially
each protein may have its own specific optimal condition.
While performing ELISA using one specific protein (rLIC20016) to evaluate the sera from our
case-control study individually, the proteome array results could not be validated. Despite this
protein target being selected as a marker for both IgM and IgG responses, the difference between
the case group and control group was not statistically significant for neither when using the ELISA
platform. The proteome array method is more sensitive than an ELISA assay, and for that reason
some of the targets selected on our high-throughput system might not be validated using a less
sensitive method. Unfortunately, we only had time to validate one protein and further analysis of
each individual proteins needs to be performed to better understand the role of each target on the
immunoprotection against reinfection.
Our preliminary results indicate that some of those targets can be potentially used to improve
prevention and the diagnostic of leptospirosis. Evaluating their function and their role on the
pathogenesis and the immunity of the disease can contribute to our better understanding of the
natural immunity against leptospirosis.
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Appendix
S1. T-test for the difference of qPCR between wild type and mutant strains by IP and CJ route

Mutant strains
LIC10829
LIC10544
LIC11941
LIC20152
LIC11510
LIC10491
LIC10050
LIC11845
LIC10010
LIC10080

P-value for IP route
<0.01*
0.691
0.574
0.514
<0.01*
0.022*
0.071
0.151
0.273
0.585

P-value for CJ route
<0.01*
<0.01*
<0.01*
<0.01*
0.025*
0.141
0.129
0.533
0.008*
0.370

S2. Information on Gene ID, name, and localization with Ig

Gene ID
LIC20152
LIC10829
LIC11623
LIC11019

Product name
Hypothetical protein
Hypothetical protein
Outer membrane protein
Putative Lipoprotein

Localization
Unknown
Extracellular
Outer Membrane
Unknown

LIC13084
LIC11186
LIC11845
LIC10544

Hypothetical protein
Putative Flagellar protein
Hypothetical protein
Outer membrane protein

Unknown
Outer Membrane
Unknown
Unknown

Ig
IgG
IgG
IgG
IgG&
IgM
IgG
IgG
IgG
IgG

LIC11073

Putative Lipoprotein

Unknown

LIC12544
LIC20016

DNA binding protein
Hypothetical protein

Unknown
Cytoplasmic Membrane

LIC10491
LIC10010
LIC10465

Acriflavin resistance
Hypothetical protein
Partial Ig-like repeatcontaining protein
Heavy metal efflux pump
Peptidoglycan-associated
cytoplasmic membrane
protein
Heavy metal efflux pump
Hypothetical protein

Cytoplasmic Membrane
Unknown
Unknown

IgG&
IgM
IgG
IgG&
IgM
IgM
IgM
IgM

Cytoplasmic Membrane
Outer Membrane

IgM
IgM

Outer Membrane
Unknown

IgM
IgM

LIC11510
LIC10050

LIC11941
LIC10080

